Table 1.
treatment | day | lymphocytes (%) | heterophils (%) | monocytes (%) | eosinophils (%) | basophils (%) |
---|---|---|---|---|---|---|
control-focal | −5 | 84.6 ± 2.5 | 11.4 ± 2.3 | 3.7 ± 1.8 | 0.3 ± 0.2 | 0 ± 0 |
2 | 82.1 ± 2.6 | 14.6 ± 3.3 | 3.1 ± 1.0 | 0.2 ± 0.1 | 0 ± 0 | |
6 | 78.8 ± 2.6 | 17.1 ± 3.6 | 3.9 ± 1.2 | 0.2 ± 0.1 | 0 ± 0 | |
12 | 82.9 ± 3.3 | 15.6 ± 3.3 | 1.4 ± 0.6 | 0 ± 0 | 0 ± 0 | |
24 | 76.8 ± 4.1 | 19.7 ± 3.9 | 2.8 ± 1.0 | 0.7 ± 0.3 | 0.1 ± 0.1 | |
MG-focal | −5 | 81.2 ± 4.3 | 17.0 ± 4.1 | 1.7 ± 0.8 | 0.1 ± 0.1 | 0 ± 0 |
2 | 74.7 ± 3.7 | 22.3 ± 3.6 | 2.7 ± 1.2 | 0.3 ± 0.2 | 0 ± 0 | |
6 | 72.3 ± 4.9 | 26.7 ± 5.0 | 0.8 ± 0.4 | 0.2 ± 0.1 | 0 ± 0 | |
12 | 70.1 ± 4.3 | 28.1 ± 4.6 | 1.6 ± 0.7 | 0.2 ± 0.1 | 0 ± 0 | |
24 | 73.2 ± 5.0 | 24.7 ± 5.3 | 1.9 ± 0.8 | 0.2 ± 0.1 | 0 ± 0 |